+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen



Factors influencing loco-regional relapse in older breast cancer patients treated with tumour resection and tamoxifen



European Journal of Surgical Oncology 37(12): 1051-1058



In breast cancer patients (≥70 years), tumour resection plus tamoxifen (T + T) has a higher loco-regional relapse (LR) rate than mastectomy. This study examines factors influencing local recurrence in these cases. Clinical records of 71 patients aged ≥70 years, randomised to the T + T arm of 2 randomised trials were reviewed. Cox Proportional Hazards model was used to determine the most significant variables. After 15-years follow-up, LR relapse occurred in 29/71, of whom 5 had synchronous metastatic disease. Most tumours recurred in the index quadrant. Subsequently 21/24 patients with loco-regional recurrence only had salvage mastectomy. Three variables significantly predicted LR: lympho-vascular invasion (LVI) (HR [95% CI]: 11.18 [4.47, 27.95], p < 0.01), ER negative status (HR [95% CI]: 0.27 [0.10, 0.72] p = 0.01), and tumour necrosis (HR [95% CI]: 2.65 [1.10, 6.37], p = 0.03). Final margin status was not associated with LR. Tumour resection + Tamoxifen in older patients results in long-term local control in the majority with most loco-regional failures being salvageable. Risk factors for LR are lympho-vascular invasion, ER status and tumour necrosis. Negative tumour excision margins did not significantly change local outcome in the absence of radiotherapy. In these older patients LVI significantly reduced survival time.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053196604

Download citation: RISBibTeXText

PMID: 21843919

DOI: 10.1016/j.ejso.2011.07.005


Related references

Pattern of loco-regional and distant failure in patients with breast cancer treated with mastectomy and chemotherapy (+/- Tamoxifen) without radiation: results from five NSABP randomized trials. International Journal of Radiation Oncology*biology*physics 51(3-Supp-S1): 106-107, 2001

Classical prognostic factors for survival and loco-regional control in breast cancer patients treated with radical mastectomy alone. Acta Oncologica (stockholm). 33(7): 759-765, 1994

Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer. Plos One 11(6): E0157196-E0157196, 2016

Transcriptomic signature predicts the distant relapse in patients with ER+ breast cancer treated with tamoxifen for five years. Molecular Medicine Reports: -, 2017

Does the tamoxifen increases thyroid dysfunction after loco-regional irradiation of breast cancer?. Radiotherapy & Oncology 59(3): 361-362, June, 2001

P-cadherin as prognostic factor for loco-regional relapse in breast cancer. Acta Medica Portuguesa 25(2): 97-105, 2013

Positive versus negative sentinel nodes in early breast cancer patients: axillary or loco-regional relapse and survival. A study spanning 2000-2012. Breast 22(5): 902-907, 2014

Patterns of local and distant disease relapse in patients with breast cancer treated with primary chemotherapy: do patients with a complete pathological response differ from those with residual tumour in the breast?. Breast Cancer Research and Treatment 93(2): 151-158, 2005

Pattern of regional failure in patients with breast cancer treated by lumpectomy, breast radiation +/- chemotherapy and/or tamoxifen with no regional radiation Results from 10 NSABP randomized trials. International Journal of Radiation Oncology Biology Physics 57(2 Supplement): S168, 2003

Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. European Journal of Surgical Oncology 33(8): 977-981, 2007

Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16. Journal of Clinical Oncology 8(6): 1005-1018, 1990

Risk factors for loco-regional recurrence in breast cancer patients: a retrospective study. Oncotarget 9(54): 30355-30362, 2018

Potent CYP2D6 Inhibiting drugs do not increase relapse rate in early breast cancer patients treated with adjuvant tamoxifen. Breast Cancer Research and Treatment 125(2): 505-510, 2011

Non-small-cell lung cancer: reirradiation for loco-regional relapse previously treated with radiation therapy. International Journal of Clinical Oncology 10(4): 247-250, 2005

The impact of isolated tumor cells on loco-regional recurrence in breast cancer patients treated with breast-conserving treatment or mastectomy without post-mastectomy radiation therapy. Breast Cancer Research and Treatment 146(2): 365-370, 2015